SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Directorate Change

5 Mar 2010 07:00

RNS Number : 1295I
Rentokil Initial PLC
05 March 2010
 



5 March 2010

 

 

 

Rentokil Initial to appoint Jeremy Townsend as Chief Financial Officer

 

Rentokil Initial plc (FTSE: RTO) today announces that Jeremy Townsend will be appointed to the Board as a Director and Chief Financial Officer on leaving his current role.

 

Jeremy Townsend, 46, is currently Finance Director at Mitchells & Butlers, a role he has held since February 2008. Jeremy joined Mitchells & Butlers in June 2005 as Deputy Finance Director. He was previously employed by J Sainsbury plc where he held various finance roles including Group Financial Controller, Corporate Finance Director and Strategy Director. Prior to Sainsbury's, he was employed by Ernst & Young, working in audit and corporate finance. Jeremy is a Fellow of the Institute of Chartered Accountants of England and Wales.

 

The date on which he will join the Board will be announced in due course.

 

Rentokil Initial's current CFO, Michael Murray, indicated some time ago that he would be minded to seek a new challenge outside Rentokil Initial if a suitable replacement could be identified. Mr Murray will leave the Board on 31 March 2010.

 

Alan Brown, Chief Executive Officer of Rentokil Initial plc, said: "We are delighted that Jeremy has chosen to join Rentokil Initial. He has highly relevant experience in managing the financial aspects of a business that operates across many sites with many brands. His expertise will be invaluable as we continue to pursue our Operational Excellence agenda.'

 

"On behalf of the Board I would like to wish Michael well for the future and thank him for his contribution during his time with the group."

There is nothing that is required to be disclosed under Listing Rule 9.6.13 in respect of Jeremy Townsend.

Ends

For further information:

Media enquiries:

Malcolm Padley, Corporate Communications Rentokil Initial plc 07788 978199

Kate Holgate, Tom Williams Brunswick Group 020 7404 5959

 

Shareholder/analyst enquiries:

Katharine Rycroft, Investor Relations Rentokil Initial plc 07811 270734

 

About Rentokil Initial

Rentokil Initial is one of the largest business services companies in the world, operating in all the major economies of Europe, North America, Asia Pacific and Africa.

www.rentokil-initial.com

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUGUPAWUPUGRC
Date   Source Headline
28th Jul 20253:00 pmRNSHolding(s) in Company
10th Jul 202511:00 amRNSHolding(s) in Company
1st Jul 202510:25 amRNSTotal Voting Rights
10th Jun 202510:05 amRNSAdditional Listing
3rd Jun 20254:00 pmRNSDirector/PDMR Shareholding
28th May 20257:00 amRNSSale of France Workwear
19th May 20252:30 pmRNSDirector/PDMR Shareholding
7th May 20254:15 pmRNSResult of AGM
7th May 20257:01 amRNSDirectorate Change: Appointment of NEDs
7th May 20257:00 amRNSDirectorate Change: Chief Executive to retire
28th Apr 20252:30 pmRNSIssue of Debt
17th Apr 20252:20 pmRNSHolding(s) in Company
17th Apr 20257:00 amRNSQ1 Trading Update
9th Apr 202510:25 amRNSHolding(s) in Company
1st Apr 20252:15 pmRNSNotice of Q1 Trading Update and Management Call
1st Apr 202510:25 amRNSBlock listing Interim Review
27th Mar 202510:25 amRNSDirector/PDMR Shareholding
26th Mar 202510:30 amRNSAnnual Financial Report
14th Mar 202510:00 amRNSDirector/PDMR Shareholding
6th Mar 20257:00 amRNSFinal Results
28th Jan 20257:00 amRNSTrading Update (unaudited)
14th Jan 202511:15 amRNSHolding(s) in Company
13th Jan 202511:15 amRNSHolding(s) in Company
13th Dec 20249:30 amRNSDirector/PDMR Shareholding
25th Nov 20247:00 amRNSDirectorate Change
12th Nov 202410:30 amRNSHolding(s) in Company
8th Nov 202410:30 amRNSHolding(s) in Company
17th Oct 20247:00 amRNSQ3 Trading Update
1st Oct 20242:00 pmRNSBlock listing Interim Review
25th Sep 20247:00 amRNSAppointment of Non-Executive Director
19th Sep 202410:30 amRNSDirector/PDMR Shareholding
11th Sep 20247:00 amRNSTrading Update
10th Sep 202410:30 amRNSHolding(s) in Company
5th Sep 202411:08 amRNSHolding(s) in Company
25th Jul 20247:00 amRNS2024 Interim Results
10th Jul 20244:35 pmRNSHolding(s) in Company
26th Jun 20245:12 pmRNSDirector/PDMR Shareholding
26th Jun 202411:08 amRNSHolding(s) in Company
17th May 20243:30 pmRNSDirector/PDMR Shareholding
8th May 20242:00 pmRNSResult of AGM
29th Apr 20243:00 pmRNSHolding(s) in Company
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.